Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study

References

• Nabhan C, Rosen ST. Chronic lymphocytic leukemia: a clinical review. JAMA 2014; 312: 2265–2276.
   PubMed Web of Science ®Google Scholar
• Redaelli A, Laskin BL, Stephens JM, et al. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl) 2004; 13: 279–287.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29.
   PubMed Web of Science ®Google Scholar
• Zent CS, Kay NE. Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach. Leuk Lymphoma 2011; 52: 1425–1434.
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446–5456.
   PubMed Web of Science ®Google Scholar
• Rosenquist R, Cortese D, Bhoi S, et al. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand? Leuk Lymphoma 2013; 54: 2351–2364.
   PubMed Web of Science ®Google Scholar
• Goustin AS, Abou-Samra AB. The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 2011; 23: 980–990.
   PubMed Web of Science ®Google Scholar
• Singh M, Sharma PK, Garg VK, et al. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol 2012; 64: 1703–1708.
   PubMed Web of Science ®Google Scholar
• Dabrowska AM, Tarach JS, Wojtysiak-Duma B, et al. Fetuin-A (AHSG) and its usefulness in clinical practice – review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015;10.5507/bp.2015.018.
   PubMed Web of Science ®Google Scholar
• Dowling P, Clarke C, Hennessy K, et al. Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer. Int J Cancer 2012; 131: 911–923.
   PubMed Web of Science ®Google Scholar
• Yi JK, Chang JW, Han W, et al. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Cancer Epidemiol Biomarkers Prev 2009; 18: 1357–1364.
   PubMed Web of Science ®Google Scholar
• Mori K, Emoto M, Inaba M. Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov 2011; 5: 124–146.
   PubMedGoogle Scholar
• Aleksandrova K, Boeing H, Nothlings U, et al. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology 2014; 60: 858–871.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Karmaniolas K, Chamberland J, et al. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metabolism 2013; 62: 1830–1839.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Crotty BH, Fargnoli J, et al. B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece. Cancer Causes Control 2010; 21: 1451–1459.
   PubMed Web of Science ®Google Scholar
• Moon HS, Dalamaga M, Kim SY, et al. Leptin’s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 2013; 34: 377–412.
   PubMed Web of Science ®Google Scholar
• Lam QL, Wang S, Ko OK, et al. Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1. Proc Natl Acad Sci U S A 2010; 107: 13812–13817.
   PubMed Web of Science ®Google Scholar
• Procaccini C, Pucino V, Mantzoros CS, et al. Leptin in autoimmune diseases. Metabolism 2015; 64: 92–104.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419–1432.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997.
   PubMed Web of Science ®Google Scholar
• Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Polyzos SA, Karmaniolas K, et al. Circulating fetuin-A in patients with pancreatic cancer: a hospital-based case-control study. Biomarkers 2014; 19: 660–666.
   PubMed Web of Science ®Google Scholar
• Kalabay L, Cseh K, Benedek S, et al. Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study. Ann Hematol 1991; 63: 264–269.
   PubMed Web of Science ®Google Scholar
• Kwak JY, Ma TZ, Yoo MJ, et al. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Exp Hematol 2004; 32: 836–842.
   PubMed Web of Science ®Google Scholar
• Majek P, Riedelova-Reicheltova Z, Suttnar J, et al. Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome. Proteome Sci 2013; 11: 14.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Chou SH, Shields K, et al. Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell Metab 2013; 18: 29–42.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437–446.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Mikhail A, Estrov Z, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 1999; 93: 1668–1676.
   PubMed Web of Science ®Google Scholar
• Choi KM, Han KA, Ahn HJ, et al. The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial. Clin Endocrinol (Oxf) 2013; 79: 356–363.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C, et al. The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance. Clinics (Sao Paulo) 2011; 66: 911–912.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Zavos C, et al. The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. J Clin Gastroenterol 2011; 45: 50–54.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 2015; 64: 60–78.
   PubMed Web of Science ®Google Scholar